FERRARI, Federica
 Distribuzione geografica
Continente #
EU - Europa 1.346
NA - Nord America 294
AS - Asia 83
OC - Oceania 7
AF - Africa 2
SA - Sud America 1
Totale 1.733
Nazione #
FR - Francia 1.137
US - Stati Uniti d'America 292
IT - Italia 91
CN - Cina 52
DE - Germania 33
CZ - Repubblica Ceca 14
SE - Svezia 12
JP - Giappone 11
NL - Olanda 11
IE - Irlanda 9
GB - Regno Unito 8
AU - Australia 7
RU - Federazione Russa 6
IN - India 5
UA - Ucraina 5
BE - Belgio 4
PL - Polonia 4
VN - Vietnam 4
DK - Danimarca 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
CA - Canada 2
ES - Italia 2
HK - Hong Kong 2
ID - Indonesia 2
MK - Macedonia 2
TW - Taiwan 2
BD - Bangladesh 1
CH - Svizzera 1
CL - Cile 1
DZ - Algeria 1
FI - Finlandia 1
IR - Iran 1
MA - Marocco 1
NO - Norvegia 1
PH - Filippine 1
Totale 1.733
Città #
Paris 248
Santa Cruz 34
Ferrara 29
Ashburn 22
Chicago 16
Boardman 14
Shanghai 12
Ferrara di Monte Baldo 11
Stockholm 11
Des Moines 10
Columbus 9
Dublin 9
New York 9
Fairfield 8
Los Angeles 8
Buffalo 7
Berlin 6
Brisbane 6
Cambridge 6
Cedar Knolls 6
Grenoble 6
Padova 6
Seattle 6
Tappahannock 6
Guangzhou 5
Bologna 4
Council Bluffs 4
Dong Ket 4
Hangzhou 4
Houston 4
Milan 4
Parsippany 4
Acqui Terme 3
Beijing 3
Brussels 3
Frankfurt am Main 3
Henderson 3
San Diego 3
Vicenza 3
Athens 2
Blagoevgrad 2
Brentonico 2
Bühl 2
Caserta 2
Catania 2
Copenhagen 2
Florence 2
Jakarta 2
Kaohsiung City 2
Kobe 2
Krakow 2
Las Vegas 2
Livermore 2
Maebashi 2
Moscow 2
Olney 2
Providence 2
Provo 2
Salerno 2
San Francisco 2
San Jose 2
Scranton 2
Tokyo 2
Warsaw 2
Woodbridge 2
Zhongshan 2
Aachen 1
Aci Catena 1
Agna 1
Ahmedabad 1
Ahvaz 1
Auburn 1
Baltimore 1
Baton Rouge 1
Bellevue 1
Bristol 1
Béjaïa 1
Böblingen 1
Casalserugo 1
Chapel Hill 1
Chefchaouen 1
Chiyoda-ku 1
Cixi 1
Clearwater 1
Corvallis 1
Dallas 1
Delhi 1
Eastbourne 1
Einbeck 1
Elmshorn 1
Ghent 1
Granada 1
Grassano 1
Greifswald 1
Hamburg 1
Hamden 1
Hanover 1
Helsinki 1
Herndon 1
Hong Kong 1
Totale 647
Nome #
Pharmacological profile of nociceptin/orphanin FQ receptor – characterization of novel peptide and non peptide ligands, file e309ade5-2291-3969-e053-3a05fe0a2c94 1.110
Structure-Activity Relationship Studies on Oxazolo[3,4- a]pyrazine Derivatives Leading to the Discovery of a Novel Neuropeptide S Receptor Antagonist with Potent in Vivo Activity, file e309ade4-cfe7-3969-e053-3a05fe0a2c94 150
Novel Mixed NOP/Opioid Receptor Peptide Agonists, file e309ade4-c82b-3969-e053-3a05fe0a2c94 63
A staged screening of registered drugs highlights remyelinating drug candidates for clinical trials, file e309ade1-4d2b-3969-e053-3a05fe0a2c94 54
Structure-and conformation-Activity studies of nociceptin/orphanin FQ receptor dimeric ligands, file e309ade3-dd14-3969-e053-3a05fe0a2c94 53
Tetrabranched Hetero-Conjugated Peptides as Bifunctional Agonists of the NOP and Mu Opioid Receptors, file e309ade3-b3df-3969-e053-3a05fe0a2c94 52
(2S)-N-2-methoxy-2-phenylethyl-6,7-benzomorphan compound (2S-LP2): Discovery of a biased mu/delta opioid receptor agonist, file e309ade4-7e91-3969-e053-3a05fe0a2c94 50
Pharmacological profile of the neuropeptide S receptor: Dynamic mass redistribution studies, file e309ade2-1260-3969-e053-3a05fe0a2c94 45
Modulation of Drosophila suzukii type 1 tyramine receptor (DsTAR1) by monoterpenes: a potential new target for next generation biopesticides, file e309ade2-9064-3969-e053-3a05fe0a2c94 44
Biased Agonism at Nociceptin/Orphanin FQ Receptors: A Structure Activity Study on N/OFQ(1-13)-NH2, file e309ade2-f967-3969-e053-3a05fe0a2c94 40
Peptide welding technology – A simple strategy for generating innovative ligands for G protein coupled receptors, file e309ade3-ecc7-3969-e053-3a05fe0a2c94 35
Pharmacological profile of nociceptin/orphanin FQ receptor – characterization of novel peptide and non peptide ligands, file e309ade5-2290-3969-e053-3a05fe0a2c94 14
Structure activity studies of nociceptin/orphanin FQ(1–13)-NH2 derivatives modified in position 5, file e309ade0-b114-3969-e053-3a05fe0a2c94 4
Tetrabranched Hetero-Conjugated Peptides as Bifunctional Agonists of the NOP and Mu Opioid Receptors, file e309ade2-4f09-3969-e053-3a05fe0a2c94 4
Modulation of Drosophila suzukii type 1 tyramine receptor (DsTAR1) by monoterpenes: a potential new target for next generation biopesticides, file e309ade2-c2e0-3969-e053-3a05fe0a2c94 4
(2S)-N-2-methoxy-2-phenylethyl-6,7-benzomorphan compound (2S-LP2): Discovery of a biased mu/delta opioid receptor agonist, file e309ade2-202a-3969-e053-3a05fe0a2c94 3
Pharmacological characterization of tachykinin tetrabranched derivatives, file e309ade0-3fd1-3969-e053-3a05fe0a2c94 2
In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparations, file e309ade1-09f6-3969-e053-3a05fe0a2c94 2
Peptide welding technology – A simple strategy for generating innovative ligands for G protein coupled receptors, file e309ade1-97a2-3969-e053-3a05fe0a2c94 2
Prevenzione e Cura della carenza di vitamina E nei pazienti colestatici: il tocofersolano (Vedrop) per via orale, file e309ade1-c815-3969-e053-3a05fe0a2c94 2
Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt(1)]N/OFQ(1-13), file e309ade1-06d1-3969-e053-3a05fe0a2c94 1
In vitro pharmacological characterization of a novel unbiased NOP receptor-selective nonpeptide agonist AT-403, file e309ade1-695a-3969-e053-3a05fe0a2c94 1
Cyclopeptide Dmt-[D-Lys-p-CF3-Phe-Phe-Asp]NH2, a novel G protein-biased agonist of the mu opioid receptor, file e309ade1-cbd3-3969-e053-3a05fe0a2c94 1
In vitro and in vivo activity of cyclopeptide Dmt-c[D-Lys-Phe-Asp]NH2, a mu opioid receptor agonist biased toward β-arrestin, file e309ade1-eb7d-3969-e053-3a05fe0a2c94 1
Synthesis and Pharmacological Evaluation of Hybrids Targeting Opioid and Neurokinin Receptors, file e309ade2-64a0-3969-e053-3a05fe0a2c94 1
Totale 1.738
Categoria #
all - tutte 3.937
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.937


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204 0 0 0 0 0 0 0 3 0 1 0 0
2020/202133 0 0 0 1 0 0 0 4 5 3 11 9
2021/2022103 5 3 2 6 6 5 9 4 12 5 32 14
2022/2023247 12 15 39 19 8 19 19 19 39 13 26 19
2023/20241.350 16 24 20 25 17 612 431 136 23 34 12 0
Totale 1.738